Drug Database
Back to search

Norway· NO-ID_A38002FD-F428-48AB-8BC8-5850F3F6207E

Copemyl

A glatiramer acetate product containing glatiramer acetate, registered in Norway by Orifarm AS. The same ATC class is registered in 14 of our 19 countries.

ATC L03AX13

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedCopemylATCL03AX13REGISTER NO.NO-ID_A38002FD-F428-4…PACKS LISTED3CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about glatiramer acetateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Glatiramer acetate is registered in 14 of 19 countries.

Countries holding a registration under ATC L03AX13 (glatiramer acetate), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 10 of them publish a price we can compare per daily dose
Search glatiramer acetate products by name

Glatiramer acetate · ATC L03AX13

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Glatiramer Acetate
Manufacturer
Orifarm AS
Country
Norway (NO)
ATC code
L03AX13
ATC class
Glatiramer acetate
Defined daily dose
20 mg, P
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_A38002FD-F428-48AB-8BC8-5850F3F6207E
  • no_varenummer
    528748
    28 x 1
    NOK 7066.3
  • gtin
    5714191012005

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for glatiramer acetate.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check glatiramer acetate against other medicinesHow interaction checks work

Glatiramer acetate · interactions on record

2 records

  • 2 severe

Most severe, free to view

  • NatalizumabL04AA23severe
  • NatalizumabL04AG03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glatiramer acetate in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glatiramer acetate products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Copaxone, Perscleran
  • Belgium · Copaxone, Glataxon
  • Bulgaria · Копаксон, Ремурел
  • Cyprus · Clift, Copaxone
  • Czechia · Copaxone, Remurel
  • Germany · Clift, Copaxone
  • Denmark · Copaxone, Copemyl
  • Estonia · Copaxone, Remurel
  • Spain · Copaxone, Glatiramero Viatris
  • Finland · Copaxone, Glatimyl
  • France · Copaxone, Copaxone Pen
  • United Kingdom (Northern Ireland) · Brabio, Copaxone
  • Greece · Clift, Copaxone
  • Croatia · Copaxone, Remurel
  • Hungary · Copaxone, Remurel
  • Ireland · Brabio, Copaxone
  • Iceland · Copaxone, Remurel
  • Italy · Copaxone, Copemyl
  • Lithuania · Copaxone, Remurel
  • Luxembourg · Copaxone, Copaxone Pen
  • Latvia · Copaxone, Remurel
  • Malta · Galtipex
  • Netherlands · Brabio, Copaxone
  • Poland · Copaxone, Remurel
  • Portugal · Acetato De Glatirâmero Viatris, Clift
  • Romania · Copaxone, Remurel
  • Sweden · Copaxone, Glatimyl
  • Slovenia · Copaxone, Remurel
  • Slovakia · Copaxone, Copaxone Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dbc184a2-279d-4b24-9ffa-7dafcfe5bc2b
GET /v1/drugs/dbc184a2-279d-4b24-9ffa-7dafcfe5bc2b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Injeksjonsvæske, oppløsning i ferdigfylt sprøyte",
  "source": "fest",
  "status": "A",
  "atc_name": "Glatirameracetat",
  "merkevare_id": "ID_A38002FD-F428-48AB-8BC8-5850F3F6207E",
  "name_form_strength": "Copemyl inj, oppl 20 mg/ml",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about glatiramer acetate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console